EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Environmental epimutagens, epigenetic memory, and cancer latency

Paola Arimondo, Xavier Coumoul, Johanna Lepeule, Marie Lopez, Charlotte Proudhon, Laurent M Sachs, Pierre-Antoine Defossez

NAR Cancer · 2026-09-30 · 8 (4)

DOI: 10.1093/narcan/zcag033 ↗
AbstractBibliografische Angaben

Abstract

Abstract Environmental exposures can cause cancer through DNA damage and mutations, but whether they can also leave durable, cancer-relevant changes in gene regulation is less clear. Chromatin helps maintain cell identity, differentiation state, and plasticity, providing a route by which non-genetic effects of exposure could persist after exposure. We define environmental epimutagens as agents or conditions that perturb chromatin regulation, and examine how such perturbations may influence cancer initiation and latency. Exposures can reach chromatin through altered metabolite or cofactor availability, interference with chromatin-regulating proteins, and direct chemical modification. Most resulting changes are transient, adaptive, or secondary. The central question is which become biologically embedded in long-lived cell populations, remain silent during latency, and alter responses to later genetic, inflammatory, or tissue-level pressures. Studies of inflammatory memory and transient disruption of chromatin repression show that short-lived perturbations can durably reprogram cellular potential, lower the threshold for tumor initiation, or generate tumorigenic states. Exposures may also influence the later selection of primed cells. Establishing causality will require physiologically realistic exposure models, longitudinal and lineage-resolved analyses, and functional tests distinguishing biomarkers of exposure from persistent mediators of cancer susceptibility. Such work may identify preventable exposures, informative biomarkers, and opportunities for cancer interception.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →